ZA883115B - Treatment of diabetes - Google Patents

Treatment of diabetes

Info

Publication number
ZA883115B
ZA883115B ZA883115A ZA883115A ZA883115B ZA 883115 B ZA883115 B ZA 883115B ZA 883115 A ZA883115 A ZA 883115A ZA 883115 A ZA883115 A ZA 883115A ZA 883115 B ZA883115 B ZA 883115B
Authority
ZA
South Africa
Prior art keywords
diabetes
treatment
fluoxetine
mammals
found
Prior art date
Application number
ZA883115A
Other languages
English (en)
Inventor
David Taiwai Wong
Taiwai Wong David
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA883115B publication Critical patent/ZA883115B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA883115A 1987-05-04 1988-05-02 Treatment of diabetes ZA883115B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4550987A 1987-05-04 1987-05-04

Publications (1)

Publication Number Publication Date
ZA883115B true ZA883115B (en) 1990-01-31

Family

ID=21938301

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA883115A ZA883115B (en) 1987-05-04 1988-05-02 Treatment of diabetes

Country Status (11)

Country Link
EP (1) EP0294028B1 (ja)
JP (1) JP2721507B2 (ja)
KR (1) KR880013555A (ja)
AT (1) ATE93721T1 (ja)
AU (1) AU596296B2 (ja)
DE (1) DE3883606T2 (ja)
DK (1) DK238588A (ja)
ES (1) ES2058272T3 (ja)
HK (1) HK19595A (ja)
PH (1) PH23901A (ja)
ZA (1) ZA883115B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2039103A1 (en) * 1990-03-29 1991-09-30 David Wayne Robertson Improvements in and relating to the selective occupation of serotonin 1c receptors
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
ES2303085T3 (es) 2003-04-29 2008-08-01 Orexigen Therapeutics, Inc. Composiciones que afectan a la perdida de peso.
BRPI0618918B8 (pt) * 2005-11-22 2021-05-25 Nalpropion Pharmaceuticals Llc uso de um primeiro composto e um segundo composto para tratar uma condição de glicose sanguínea
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
KR20190042766A (ko) 2006-11-09 2019-04-24 오렉시젠 세러퓨틱스 인크. 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
MX343867B (es) 2006-11-09 2016-11-25 Orexigen Therapeutics Inc Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso.
MX2010012909A (es) 2008-05-30 2011-02-25 Orexigen Therapeutics Inc Metodos para tratamiento de condiciones de grasa visceral.
AU2011203867B2 (en) 2010-01-11 2015-12-03 Nalpropion Pharmaceuticals Llc Methods of providing weight loss therapy in patients with major depression
EP2858640B1 (en) 2012-06-06 2020-03-25 Nalpropion Pharmaceuticals LLC Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk
WO2014021802A1 (en) 2012-07-31 2014-02-06 Sanovel Hayvan Sagligi Ürünleri Sanayi Ve Ticaret A.S. Use of fluoxetine for increasing meat and milk production
EA201590044A1 (ru) 2012-07-31 2015-09-30 Сановел Хайван Саглиги Юрюнлери Санайи Ве Тиджарет А.С. Применение флуоксетина у животных
US8969371B1 (en) 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4590213A (en) * 1983-04-08 1986-05-20 Eli Lilly And Company Anti-anxiety method
ZA861211B (en) * 1985-02-25 1987-10-28 Lilly Co Eli Analgesic composition

Also Published As

Publication number Publication date
JPS63284126A (ja) 1988-11-21
AU596296B2 (en) 1990-04-26
DK238588D0 (da) 1988-05-03
EP0294028A3 (en) 1990-05-02
KR880013555A (ko) 1988-12-21
EP0294028A2 (en) 1988-12-07
DK238588A (da) 1988-11-05
HK19595A (en) 1995-02-17
ES2058272T3 (es) 1994-11-01
JP2721507B2 (ja) 1998-03-04
ATE93721T1 (de) 1993-09-15
DE3883606T2 (de) 1994-01-20
PH23901A (en) 1989-12-18
EP0294028B1 (en) 1993-09-01
AU1553388A (en) 1988-11-10
DE3883606D1 (de) 1993-10-07

Similar Documents

Publication Publication Date Title
JPS5791915A (en) Novel lipid composition useful for dietetics, resuscitation and treatment
ZA883115B (en) Treatment of diabetes
ZA859286B (en) Novel treatment
IE882529L (en) Platinum Coordination Compound
PT84294A (en) Novel treatment
ZA857721B (en) Process for treatment of rheumatic diseases
GB2198451B (en) Briquette treatment process
GB2158112B (en) Treatment process for utilization of rubber wood
GB2206821B (en) Improvements relating to surface treatment
ZA884799B (en) Novel treatment
EP0238765A3 (en) 2,2-diphenoxy-n,n-dimethylaminoethane for improving cerebral oxygenation
GB8622419D0 (en) Treatment/therapy for diabetes sufferes
ZA883322B (en) Yeast treatment process
GB8711457D0 (en) Treatment
GB8709875D0 (en) Treatment
GB8718587D0 (en) Treatment
GB8712248D0 (en) Treatment
GB8712246D0 (en) Treatment
GB8716648D0 (en) Treatment
GB8712241D0 (en) Treatment
GB8712239D0 (en) Treatment
GB8712245D0 (en) Treatment
GB8708042D0 (en) Treatment
GB8716533D0 (en) Treatment
GB8716534D0 (en) Treatment